Adjuvant S-1 extends OS in biliary tract cancers

被引：0
|
作者：
Romero, Diana
机构：
[1] Nature Reviews Clinical Oncology,
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2023年 / 20卷 / 3期
关键词：
D O I：
10.1038/s41571-023-00738-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [21] Adjuvant Therapy for Biliary Tract Cancers: Desperately Seeking Data
    Cao, Hop S. Tran
    Massarweh, Nader N.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (12) : 719 - 721
  • [22] The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis
    Ryoga Hamura
    Koichiro Haruki
    Tomohiko Taniai
    Mitsuru Yanagaki
    Yoshihiro Shirai
    Kenei Furukawa
    Teruyuki Usuba
    Shuichi Fujioka
    Tomoyoshi Okamoto
    Yukio Nakabayashi
    Tadashi Uwagawa
    Toru Ikegami
    International Journal of Clinical Oncology, 2022, 27 : 1188 - 1195
  • [23] The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis
    Hamura, Ryoga
    Haruki, Koichiro
    Taniai, Tomohiko
    Yanagaki, Mitsuru
    Shirai, Yoshihiro
    Furukawa, Kenei
    Usuba, Teruyuki
    Fujioka, Shuichi
    Okamoto, Tomoyoshi
    Nakabayashi, Yukio
    Uwagawa, Tadashi
    Ikegami, Toru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1188 - 1195
  • [24] Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer
    Hosoda, Kiyotaka
    Fukushima, Kentaro
    Shimizu, Akira
    Motoyama, Hiroaki
    Kubota, Koji
    Notake, Tsuyoshi
    Sugenoya, Shinsuke
    Hayashi, Hikaru
    Yasukawa, Koya
    Kobayashi, Ryoichiro
    Soejima, Yuji
    ONCOLOGY, 2021, 99 (11) : 703 - 712
  • [25] Efficacy markers for cisplatin and S-1 in biliary tract carcinoma.
    Sakamoto, Yasunari
    Ojima, Hidenori
    Morizane, Chigusa
    Yamagishi, Seri
    Hosoi, Hiroko
    Kondo, Shunsuke
    Ueno, Hideki
    Okusaka, Takuji
    Kanai, Yae
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [26] Clinician's challenge to biliary tract cancers
    Ohba, Akihiro
    CANCER SCIENCE, 2023, 114 : 179 - 179
  • [27] Current standards and future perspectives in adjuvant treatment for biliary tract cancers
    Lamarca, Angela
    Edeline, Julien
    McNamara, Mairead G.
    Hubner, Richard A.
    Nagino, Masato
    Bridgewater, John
    Primrose, John
    Valle, Juan W.
    CANCER TREATMENT REVIEWS, 2020, 84
  • [28] Phase II study of S-1 in patients with advanced biliary tract cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Takezako, Y
    Morizane, C
    BRITISH JOURNAL OF CANCER, 2004, 91 (10) : 1769 - 1774
  • [29] Phase II study of S-1 in patients with advanced biliary tract cancer
    H Ueno
    T Okusaka
    M Ikeda
    Y Takezako
    C Morizane
    British Journal of Cancer, 2004, 91 : 1769 - 1774
  • [30] Efficacy and safety of S-1 following gemcitabine with cisplatin for biliary tract cancer
    Inoue, H.
    Yamazaki, K.
    Shirasu, H.
    Kawakami, T.
    Todaka, A.
    Tsushima, T.
    Hamauchi, S.
    Yokota, T.
    Machida, N.
    Fukutomi, A.
    Onozawa, Y.
    Yasui, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S111 - S112
12345